Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy

Journal of Proteomics

Volumn 75, Issue 7, 2012, Pages 2196-2204

  Csosz, Éva ^a   Boross, Péter ^a   Csutak, Adrienne ^a,c   Berta, András ^a,c   Tóth, Ferenc ^a   Póliska, Szilárd ^b   Török, Zsolt ^d   Tozsér, József ^a,c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UD GenoMed Ltd   (Hungary)

^c Inno Tears Ltd   (Hungary)

^d Astrid Research Ltd   (Hungary)

Author keywords

Biomarker; Diabetic retinopathy; ITRAQ; Quantitative mass spectrometry

Indexed keywords

IMMUNOGLOBULIN LAMBDA CHAIN; LACRITIN; LACTOFERRIN; LIPOCALIN 1; LIPOPHILIN A; LYSOZYME CHLORIDE; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LACRIMAL FLUID; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

BIOLOGICAL MARKERS; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEOME; TEARS;

EID: 84858751820     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.01.019     Document Type: Article

References (43)

1. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
2. Cheung N., Mitchell P., Wong T.Y. Diabetic retinopathy. Lancet 2010, 10:124-136.
3. Sapieha P., Hamel D., Shao Z., Rivera J.C., Zaniolo K., Joyal J.S., et al. Proliferative retinopathies, angiogenesis that blinds. Int J Biochem Cell Biol 2010, 42:5-12.
4. Van Haeringen N.J. Clinical biochemistry of tears. Surv Ophthalmol 1981, 26:84-96.
5. Dilly P.N. Structure and function of the tear film. Adv Exp Med Biol 1994, 350:239-247.
6. Fleiszig S.M., McNamara N.A., Evans D.J. The tear film and defense against infection. Adv Exp Med Biol 2002, 506:523-530.
7. Berta A. Standardization of tear protein determinations. The effects of sampling, flow rate, and vascular permeability. The Preocular Tear Film in Health, Disease, and Contact Lens Wear 1986, 418-435. Dry Eye Institute, Lubbock. F.J. Holly (Ed.).
8. Zhou L., Huang L.Q., Beuerman R.W., Grigg M.E., Li S.F., Chew F.T., et al. Proteomic analysis of human tears: defensin expression after ocular surface surgery. J Proteome Res 2004, 3:410-416.
9. Zhou L., Beuerman R.W., Huang L., Barathi A., Foo Y.H., Li S.F., et al. Proteomic analysis of rabbit tear fluid: defensin levels after an experimental corneal wound are correlated to wound closure. Proteomics 2007, 7:3194-3206.
10. Zhou L., Beuerman R.W., Ang L.P., Chan C.M., Li S.F., Chew F.T., et al. Elevation of human alpha-defensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium. Invest Ophthalmol Vis Sci 2009, 50:2077-2086.
11. Csutak A., Silver D.M., Tozsér J., Steiber Z., Bagossi P., Hassan Z., et al. Plasminogen activator inhibitor in human tears after laser refractive surgery. J Cataract Refract Surg 2008, 34:897-901.
12. Sariri R., Ghafoori H. Tear proteins in health, disease, and contact lens wear. Biochemistry (Mosc) 2008, 73:381-392.
13. Koo B.S., Lee D.Y., Ha H.S., Kim J.C., Kim C.W. Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis. J Proteome Res 2005, 4:719-724.
14. Kuizenga A., van Haeringen N.J., Kijlstra A. SDS-Minigel electrophoresis of human tears. Effect of sample treatment on protein patterns. Invest Ophthalmol Vis Sci 1991, 32:381-386.
15. Molloy M.P., Bolis S., Herbert B.R., Ou K., Tyler M.I., van Dyk D.D., et al. Establishment of the human reflex tear two-dimensional polyacrylamide gel electrophoresis reference map: new proteins of potential diagnostic value. Electrophoresis 1997, 18:2811-2815.
16. Herber S., Grus F.H., Sabuncuo P., Augustin A.J. Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis 2001, 22:1838-1844.
17. Zhou L., Beuerman R.W., Barathi A., Tan D. Analysis of rabbit tear proteins by high-pressure liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom 2003, 17:401-412.
18. Grus F.H., Podust V.N., Bruns K., Lackner K., Fu S., Dalmasso E.A., et al. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci 2005, 46:863-876.
19. Zhou L., Beuerman R.W., Foo Y., Liu S., Ang L.P., Tan D.T. Characterisation of human tear proteins using high-resolution mass spectrometry. Ann Acad Med Singapore 2006, 35:400-407.
20. Li N., Wang N., Zheng J., Liu X.M., Lever O.W., Erickson P.M., et al. Characterization of human tear proteome using multiple proteomic analysis techniques. J Proteome Res 2005, 4:2052-2061.
21. Varnell R.J., Freeman J.Y., Maitchouk D., Beuerman R.W., Gebhardt B.M. Detection of substance P in human tears by laser desorption mass spectrometry and immunoassay. Curr Eye Res 1997, 16:960-963.
22. Sack R.A., Conradi L., Krumholz D., Beaton A., Sathe S., Morris C. Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Invest Ophthalmol Vis Sci 2005, 46:1228-1238.
23. Zhou L., Beuerman R.W., Chan C.M., Zhao S.Z., Li X.R., Yang H., et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res 2009, 8:4889-4905.
24. de Souza G.A., Godoy L.M., Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol 2006, 10.1186/gb-2006-7-8-r72.
25. Li Z.Z., Lu X.Z., Liu J.B., Chen L. Serum retinol-binding protein 4 levels in patients with diabetic retinopathy. J Int Med Res 2010, 38:95-99.
26. Tao Y., Lu Q., Jiang Y.R., Qian J., Wang J.Y., Gao L., et al. Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2010, 51:4237-4242.
27. Kant S., Seth G., Anthony K. Vascular endothelial growth factor-A (VEGF-A) in vitreous fluid of patients with proliferative diabetic retinopathy. Ann Ophthalmol (Skokie) 2009, 41:170-173.
28. Praidou A., Klangas I., Papakonstantinou E., Androudi S., Georgiadis N., Karakiulakis G., et al. Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy. Curr Eye Res 2009, 34:152-161.
29. Hernández C., Ortega F., García-Ramírez M., Villarroel M., Casado J., García-Pascual L., et al. Lipopolysaccharide-binding protein and soluble CD14 in the vitreous fluid of patients with proliferative diabetic retinopathy. Retina 2010, 30:345-352.
30. Takada M., Ban Y., Yamamoto G., Ueda T., Saito Y., Nishimura E., et al. Periostin, discovered by nano-flow liquid chromatography and mass spectrometry, is a novel marker of diabetic retinopathy. Biochem Biophys Res Commun 2010, 399:221-226.
31. Kim K., Kim S.J., Yu H.G., Yu J., Park K.S., Jang I.J., et al. Verification of biomarkers for diabetic retinopathy by multiple reaction monitoring. J Proteome Res 2010, 9:689-699.
32. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004, 3:1154-1169.
33. DeSouza L., Diehl G., Rodrigues M.J., Guo J., Romaschin A.D., Colgan T.J., et al. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res 2005, 4:377-386.
34. Berta A. Collection of tear samples with or without stimulation. Am J Ophthalmol 1983, 96:115-116.
35. Yu L., Chen X., Qin G., Xie H., Lv P. Tear film function in type 2 diabetic patients with retinopathy. Ophthalmologica 2008, 222:284-291.
36. Zhao Z., Liu J., Shi B., He S., Yao X., Willcox M.D. Advanced glycation end product (AGE) modified proteins in tears of diabetic patients. Mol Vis 2010, 16:1576-1584.
37. Moschos M.M., Rouvas A.A., Papadimitriou S., Kotsolis A., Sitaras N., Apostolopoulos M. Quantitative determination of glycosaminoglycans in tears of diabetic patients. Clin Ophthalmol 2008, 2:581-584.
38. McGill J.I., Liakos G.M., Goulding N., Seal V. Normal tear protein profiles and age-related changes. Br J Ophthalmol 1984, 68:316-320.
39. Sjödin A., Guo D., Sørhaug S., Bjermer L., Henriksson R., Hedman H. Dysregulated secretoglobin expression in human lung cancers. Lung Cancer 2003, 41:49-56.
40. Wang J., Wang N., Xie J., Walton S.C., McKown R.L., Raab R.W., et al. Restricted epithelial proliferation by lacritin via PKCalpha-dependent NFAT and mTOR pathways. J Cell Biol 2006, 174:689-700.
41. Flower D.R. The lipocalin protein family: structure and function. Biochem J 1996, 318:1-14.
42. Noy N. Retinoid-binding proteins: mediators of retinoid action. Biochem J 2000, 348:481-495.
43. Gimeno-Orna J.A., Faure-Nogueras E., Castro-Alonso F.J., Boned-Juliani B. Ability of retinopathy to predict cardiovascular disease in patients with type 2 diabetes mellitus. Am J Cardiol 2009, 103:1364-1367.